RecruitingAlcohol-related Liver DiseaseLiver Diseases
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this trial is to see if providing patients with alcohol-related liver disease with tailored alcohol use treatment options will increase engagement with treatment and correct possible misconceptions.
Sponsor: Henry Ford Health System
You may qualify if…
- ✓ Willingness to comply with all study procedures and availability for the duration of the study
- ✓ Willing and able to provide informed consent
- ✓ Enrolled at University of Michigan (UM) hepatology clinics or inpatients at UM Hospitals
- ✓ Documented diagnosis of alcohol-related liver disease (ALD) (per protocol)
- ✓ Recent alcohol use of any amount within the past 6 months as assessed by either patient interview, medical chart review, or positive alcohol biomarker (e.g. blood alcohol level, urinary ethyl glucuronide, urinary ethyl sulfate, or phosphatidylethanol) in the medical record.
- ✓ No alcohol use treatment within the past 1 month including, but not limited to:
- ✓ Any professionally lead therapy with a mental health counselor (such as, one-on-one therapy, group therapy, couples or family therapy) with a primary aim of alcohol abstinence or reduction in alcohol use.
- ✓ Community-based alcohol recovery groups (such as, Alcoholics Anonymous, SMART Recovery, Celebrate Recovery, Refuge Recovery)
You may not qualify if…
- ✕ Unable to provide voluntary informed consent for any reason
- ✕ Substantially cognitively impaired as evidenced by Westhaven grade 2 or higher hepatic encephalopathy or a score \>=10 on the Short Blessed Test for cognitive impairment.
- ✕ Unable to read or understand English
- ✕ Undergoing active evaluation for liver transplantation, is listed for liver transplant, or is post-transplantation
- ✕ Is enrolled in the multidisciplinary ALD clinic at Michigan Medicine
- ✕ Any other medical condition or circumstance that precludes safe and meaningful participation in the study
- ✕ History of nonadherence to previous clinical or research studies
Where it's recruiting
Michigan
Detroit
Source: ClinicalTrials.gov · NCT06269510 · last updated 2026-02-03